The protective role of Nrf2/Keap1 in neurological disease and oxidative stress-induced cell damage
Sammanfattning
Oxidative stress is a common feature in the pathogenesis of many diseases, including neurodegenerative diseases like Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS). Nrf2 and Keap1 regulate an inducible defence system against oxidative stress. In addition to oxidative stress, the Nrf2-dependent defence system is also triggered by reactive substances in our diet, such as the isothiocyanate sulforaphane from broccoli, and both broccoli and sulforaphane have been shown to protect from disease in a number of studies. The aim of this thesis has been to investigate the Nrf2 response after repeated, short stimulations with sulforaphane, simulating the brief Nrf2 stimulation expected after regular broccoli intake. Furthermore, genetic variation in the Nrf2- and Keap1-encoding genes NFE2L2 and KEAP1 were investigated for associations with PD and ALS. In paper I, we found that brief stimulation of Nrf2 with sulforaphane was enough to induce a prolonged Nrf2 response in astrocytes. We also found that repeated four-hour stimulations for several days resulted in sustained increase in the resistance to superoxide-induced cell death and an accumulation of one of the protective enzymes induced by Nrf2. The results of paper II indicate that brief sulforaphane treatment repeated for three consecutive days increased radioresistance in an Nrf2-dependent manner, suggesting that the Nrf2 system can be trained. In paper III and IV, we found that genetic variants of the NFE2L2 gene may affect risk and phenotype of both PD and ALS. We also found that a genetic variant of the KEAP1 gene may affect the phenotype of ALS. In conclusion, data presented in this thesis indicate that Nrf2 can be activated by brief, repeated stimulations to protect from oxidative stress-induced damage. In addition, NFE2L2 may be a risk gene for both PD and ALS, while KEAP1 may affect the phenotype of ALS.
Delarbeten
I. Bergström P. et al. Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage.
Neuropharmacology. 2011 Feb-Mar;60(2-3):343-53. ::doi::10.1016/j.neuropharm.2010.09.023 II. Sherin M., Bergström P., Hammarsten O. Repeated transient Nrf2 stimulation protects primary human fibroblasts from radiation-induced damage III. von Otter M et al. Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease. BMC Med Genet. 2010 Mar 2;11:36. ::doi::10.1186/1471-2350-11-36 IV. Bergström et al. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis
Examinationsnivå
Doctor of Philosophy (Medicine)
Universitet
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Biomedicine. Department of Clinical Chemistry and Transfusion Medicine
Disputation
kl 09.00, hörsal Hjärtat, SU
Datum för disputation
2013-06-11
E-post
petra.bergstrom@clinchem.gu.se
Datum
2013-05-22Författare
Bergström, Petra
Nyckelord
amyotrophic lateral sclerosis
astrocytes
haplotype
Keap1
KEAP1
neuroprotection
NFE2L2
Nrf2
oxidative stress
Parkinson’s disease
risk factor
SNP
sulforaphane
genetic variation
Publikationstyp
Doctoral thesis
ISBN
978-91-628-8670-7
Språk
eng